Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation

Lung cancer patients harbouring driver oncogene alterations are markedly responsive to molecular target agents, such as epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor (TKI), and echinoderm microtubule-associated protein like 4 – anaplastic lymphoma kinase (EML4-ALK)-TKI. We encou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Respir Med Case Rep
Hlavní autoři: Fujita, Kohei, Naka, Megumi, Ito, Takanori, Kanai, Osamu, Maekawa, Koichi, Nakatani, Koichi, Mio, Tadashi
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8024693/
https://ncbi.nlm.nih.gov/pubmed/33854939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2021.101393
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky